Triple

T22717324
Position Surface form Disambiguated ID Type / Status
Subject fluconazole E561768 entity
Predicate hasDrugInteraction P68633 FINISHED
Object phenytoin NE NERFINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: phenytoin | Statement: [fluconazole, hasDrugInteraction, phenytoin]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: phenytoin
Context triple: [fluconazole, hasDrugInteraction, phenytoin]
  • A. phenytoin chosen
    Phenytoin is an antiepileptic medication commonly used to prevent and control seizures by stabilizing neuronal activity in the brain.
  • B. carbamazepine
    Carbamazepine is an anticonvulsant and mood-stabilizing drug commonly used to treat epilepsy, trigeminal neuralgia, and bipolar disorder.
  • C. valproate
    Valproate is an anticonvulsant and mood-stabilizing medication widely used to treat epilepsy, bipolar disorder, and to prevent migraine headaches.
  • D. lamotrigine
    Lamotrigine is an anticonvulsant medication primarily used to treat epilepsy and bipolar disorder by stabilizing neuronal activity and reducing the frequency of seizures or mood episodes.
  • E. vigabatrin
    Vigabatrin is an antiepileptic medication that irreversibly inhibits GABA transaminase to increase brain GABA levels, used mainly for refractory seizures such as infantile spasms but associated with risks like permanent visual field loss.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (2 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69e2454fc984819088213b58ee87a002 completed April 17, 2026, 2:35 p.m.
NER Named-entity recognition batch_69f1790ecbc48190926d16b20b674dbd completed April 29, 2026, 3:20 a.m.
Created at: April 17, 2026, 3:19 p.m.